Shared decision-making for low-risk thyroid cancer treatment
Part of Cancer, Hormones & metabolism clinical trials.
This study helps patients with small, low-risk thyroid cancer choose between active surveillance and immediate surgery. It focuses on shared decision-making to match the treatment to your values and preferences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a thyroid nodule 1 cm or smaller that is either suspicious or confirmed as papillary thyroid cancer, or is a certain atypical type with a BRAF mutation.
- The cancer has not spread to lymph nodes, other parts of the body, or nearby tissues.
- The tumor is not a high-risk subtype like diffuse sclerosing or columnar cell variant.
- You can commit to regular follow-up appointments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
This study tests whether a decision-making tool helps patients with low-risk thyroid cancer or suspicious thyroid nodules (small lumps) feel more confident about their treatment choices. The tool is designed to help you understand your options before meeting with a surgeon.
This trial is for patients with a small thyroid cancer (1 cm or less) that is not aggressive. It tests whether taking thyroid hormone to keep TSH low is necessary during active surveillance (watching the cancer closely instead of removing it right away).
This study looks at how people make decisions about early-stage thyroid cancer care. If your tumor is small and hasn't spread, researchers want to learn from your experience.
This study is testing whether it is safe to simply monitor (watch closely) a small thyroid nodule that has a certain biopsy result (Bethesda IV) instead of removing it right away. You would not receive a treatment, but would have regular checkups and ultrasounds to see if the nodule changes.
This study compares two approaches after thyroid surgery: giving radioactive iodine right away versus deciding based on follow-up test results. It aims to see which approach better helps people with intermediate-risk differentiated thyroid cancer.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.